Mammography vendor Planmed of Roselle, IL, will supply more than 100 mammography systems, many equipped with stereotactic biopsy devices, for a breast cancer screening project in China.
The project is China's first attempt to use large-volume screening for gathering data on breast cancer prevalence in the country, and will screen 1 million women over a period of four to six years, the company said. The project will be under the direction of the Chinese Ministry of Health and the Chinese Anti-Cancer Association, with participation by the American Cancer Society and the RSNA.
All the mammography units will be equipped with computed radiography digital imaging plates, and will be installed in screening centers throughout 50 cities. In addition, 30 units will be installed in buses to accommodate women living outside urban areas. Diagnostic image viewing will be conducted at the Beijing Expert Consulting Center Central Model Clinic, which will also serve as the administrative and educational center for the project, Planmed said.
By AuntMinnie.com staff writers
March 15, 2005
Related Reading
Road to RSNA, Planmed, November 10, 2004
Road to RSNA, Planmed, November 17, 2003
Planmed, SourceOne link up, April 4, 2003
Planmed debuts MaxView breast compression system, September 24, 2001
Copyright © 2005 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
